Interleukin- lβ increases the activity of superoxide dismutase in rat pancreatic islets

Endocrinology

Volumn 130, Issue 5, 1992, Pages 2851-2857

  Hakan Borg, L A ^a   Cagliero, Enrico ^a   Sandler, Stellan ^a   Welsh, Nils ^a   Eizirik, Decio L ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COPPER; DACTINOMYCIN; INTERLEUKIN 1BETA; MANGANESE; MESSENGER RNA; OXYGEN RADICAL; SUPEROXIDE DISMUTASE; ZINC;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; INSULIN RELEASE; MALE; NONHUMAN; NORTHERN BLOTTING; PANCREAS FUNCTION; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ACTINS; ANIMAL; CELLS, CULTURED; DACTINOMYCIN; ENZYME INDUCTION; HUMAN; INTERLEUKIN-1; ISLETS OF LANGERHANS; KINETICS; MALE; METHYLUREA COMPOUNDS; PHENANTHROLINES; PROTEINS; RATS; RATS, INBRED STRAINS; RECOMBINANT PROTEINS; RNA, MESSENGER; SUPEROXIDE DISMUTASE; SUPPORT, NON-U.S. GOV'T; THIOPHENES;

EID: 0026633029     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.130.5.1533363     Document Type: Article

References (62)

1. Nerup J, Mandrup-Poulsen T, Mølvig J, Helqvist S, Wogensen L, Egeberg J 1988 Mechanisms of pancreatic β-cell destruction in type 1 diabetes. Diabetes Care [Suppl 1] 11:16-23
2. Bendtzen K 1989 Immune hormones (cytokines): Pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 2:177-189
3. Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA 1987 Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand [Sect C] 95:55-63
4. Sandler S, Bendtzen K, Borg LAH, Eizirik DL, Strandell E, Welsh N 1989 Studies on the mechanism causing inhibition of insulin secretion in rat pancreatic islets exposed to interleukin 1β indicate a perturbation in the mitochondrial function. Endocrinology 124:1492-1501
5. Bendtzen K, Mandrup-Poulsen T, Nerup J, Dinarello CA, Svenson M, Nielsen JH 1986 Cytotoxicity of human pi 7 interleukin-1 for pancreatic islets of Langerhans. Science 232:1545-1547
6. Sandler S, Andersson A, Hellerstrom C 1987 Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121:1424-1431
7. Eizirik DL, Strandell E, Bendtzen K, Sandler S 1988 Functional characteristics of rat pancreatic islets maintained in culture following exposure to human interleukin 1. Diabetes 37:916-919
8. Spinas GA, Hansen BS, Linde S, Kasten W, Molvig J, Mandrup-Poulsen T, Dinarello CA, Nielsen JH, Nerup J 1987 Interleukin-1 dose-dependently affects the biosynthesis of (pro)insulin in isolated islets of Langerhans. Diabetologia 30:474-480
9. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL 1990 Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer cultures. J Clin Endocrinol Metab 71:152-156
10. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J 1987 Human tumor necrosis factor potentiates interleukin 1-mediated rat pancreatic β-cell toxicity. J Immunol 139:4077-4082
11. Eizirik DL 1988 Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol (Copenh) 119:321-325
12. Pukel C, Baquerizo H, Rabinovitch A 1988 Destruction of rat islet monolayers by cytokines. Synergistic interactions of interferon y, tumor necrosis factor, lymphotoxin, and interleukin-1. Diabetes 37:133-136
13. Hammonds P, Beggs M, Beresford G, Espinal J, Clarke J, Mertz RJ 1990 Insulin-secreting 0-cells possess specific receptors for interleukin-1. FEBS Lett 261:97-100
14. Eizirik DL, Tracey DE, Bendtzen K, Sandler S 1991 An interleukin-1 receptor antagonist protein (IRAP) protects insulin-producing beta-cells against suppressive effects of interleukin-1β. Diabetologia 34:445-448
15. Eizirik DL, Bendtzen K, Sandler S 1991 Short exposure of rat pancreatic islets to interleukin-1β induces a sustained but reversible impairment in β-cell function: Influence of protease activation, gene transcription, and protein synthesis. Endocrinology 128:1611-1616
16. Welsh N, Bendtzen K, Sandler S 1991 Influence of protease on inhibitory and stimulatory effects of interleukin-1β on β-cell function. Diabetes 40:290-294
17. Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML 1990 Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 86:856-863
18. Eizirik DL 1991 Interleukin-10 induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity 10:107-113
19. Southern C, Schulster D, Green IC 1990 Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-a via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276:42-44
20. Welsh N, Eizirik DL, Bendtzen K, Sandler S 1991 Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129:3167-3173
21. Eizirik DL, Sandler S, Hallberg A, Bendtzen K, Sener A, Malaisse WJ 1989 Differential sensitivity to β-cell secretagogues in rat pancreatic islets exposed to human interleukin-1β. Endocrinology 125:752-759
22. Hughes JH, Watson MA, Easom RA, Turk J, McDaniel ML 1990 Interleukin-1 induces rapid and transient expression of the c-fos proto-oncogene in isolated pancreatic islets and in purified 0-cells. FEBS Lett 266:33-36
23. Eizirik DL, Welsh M, Strandell E, Welsh N, Sandler S 1990 Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 127:2290-2297
24. Helqvist S, Polla BS, Johannesen J, Nerup J 1991 Heat shock protein induction in rat pancreatic islets by human recombinant interleukin 1β. Diabetologia 34:150-156
25. Welsh N, Welsh M, Lindquist S, Eizirik DL, Bendtzen K, Sandler S 1991 Interleukin-1β increases the biosynthesis of the heat shock protein hsp70 and selectively decreases the biosynthesis of five proteins in rat pancreatic islets. Autoimmunity 9:33-40
26. Freeman BA, Crapo JD 1982 Biology of disease. Free radicals and tissue injury. Lab Invest 47:412-426
27. Masuda A, Longo DL, Kobayashi Y, Appella E, Oppenheim J, Matsushima K 1988 Induction of mitochondrial manganese superoxide dismutase by interleukin 1. FASEB J 2:3087-3091
28. Wong GHW, Goeddel DV 1988 Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science 242:941-944
29. Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS 1990 Regulation of manganese superoxide dismutase by lipopolysaccha-ride, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J Biol Chem 265:2856-2864
30. Harris CA, Derbin KS, Hunte-McDonough B, Krauss MR, Chen KT, Smith DM, Epstein LB 1991 Manganese superoxide dismutase is induced by IFN-7 in multiple cell types. Synergistic induction by IFN-7 and tumour necrosis factor or IL-1. J Immunol 147:149-154
31. Sumoski W, Baquerizo H, Rabinovitch A 1989 Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologie 32:792-796
32. Svenson M, Bendtzen K 1988 Interleukin 1 inhibitor in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line. Scand J Immunol 27:593-599
33. Carter DB, Deibel MR, Dunn CJ, Tomich CSC, Laborde AL, Slightom J, Berger AE, Bienkowski MJ, Sun FF, McEwan RN, Harris PKW, Yem AW, Waszak GA, Chosay JG, Sieu LC, Hardee MM, Zurcher-Neely HA, Reardon IM, Heinrikson RL, Truesdell SE, Shelly JA, Eessalu TE, Taylor BM, Tracey DE 1990 Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344:633-638
34. Schnell AH, Swenne I, Borg LAH 1988 Lysosomes and pancreatic islet function. A quantitative estimation of crinophagy in the mouse pancreatic B-cell. Cell Tissue Res 252:9-15
35. Andersson A 1978 Isolated mouse pancreatic islets in culture: Effects of serum and different culture media on the insulin production of the islets. Diabetologia 14:397-404
36. Hinegardner RT 1971 An improved fluorometric assay for DNA. Anal Biochem 39:197-201
37. Eriksson UJ, Borg LAH 1991 Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331
38. Rotilio G, Bray RC, Fielden EM 1972 A pulse radiolysis study of superoxide dismutase. Biochim Biophys Acta 268:605-609
39. Forman HJ, Fridovich I 1973 Superoxide dismutase: A comparison of rate constants. Arch Biochem Biophys 158:396-400
40. Marklund SL 1982 Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sei USA 79:7634-7638
41. Johansson LH, Borg LAH 1988 A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174:331-336
42. Thomas PS 1980 Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sei USA 77:5201-5205
43. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M 1988 Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 82:735-738
44. 2) locus on chromosome 6. Nucleic Acids Res 15:7654
45. Scherman L, Dafni N, Lieman-Hurwitz J, Groner Y 1983 Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA. Proc Natl Acad Sei USA 80:5465-5469
46. Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L 1983 Isolation and characterization of full-length cDNA clones for human α-, β-, and γ-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol 3:787-795
47. Bannister JV, Bannister WH, Rotilio G 1987 Aspects of the structure, function, and applications of superoxide dismutase. Crit Rev Biochem 22:111-180
48. Czapski G, Ilan Y 1978 On the generation of the hydroxylation agent from superoxide radical: Can the Haber-Weiss reactions be the source of -OH radicals? Photochem Photobiol 28:651-653
49. McCord JM 1980 Oxygen free radicals: Release and activities. A superoxide-activated chemotactic factor and its role in the inflammatory process. Agents Actions 10:522-527
50. DiSilvestro RA, David EA, Collignon C 1991 Interleukin 1 slowly increases lung fibroblast Cu-Zn superoxide activity levels. Proc Soc Exp Biol Med 197:197-200
51. Matsubara T, Ziff M 1986 Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 137:3295-3298
52. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG 1989 Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-a. Biochem J 263:539-545
53. Heikkila RE, Cabbat FS 1978 Protection against alloxan-induced diabetes in mice by the hydroxyl radical scavenger dimethylurea. Eur J Pharmacol 52:57-60
54. Fischer LJ, Hamburger SA 1980 Dimethylurea: A radical scavenger that protects isolated pancreatic islets from the effects of alloxan and dihydroxyfumarate exposure. Life Sci 26:1405-1409
55. Sandler S, Andersson A 1982 The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-in-duced diabetes in the mouse in vivo and in vitro. Diabetologia 23:374-378
56. Eizirik DL, Lucio MA, Boschero AC, Hoffmann ME 1986 1, 10-Phenantroline, a metal chelator, protects against alloxan- but not streptozotocin-induced diabetes. J Free Rad Biol Med 2:189-192
57. Papaccio G, Pisanti FA, Frascatore S 1986 Acetyl-homocysteine thiolactone-induced increase of superoxide dismutase counteracts the effect of subdiabetogenic doses of streptozotocin. Diabetes 35:470-474
58. Totaro AE, Pisanti FA, Liberatori E 1985 Possible interrelation of acetyl-homocysteine-thiolactone in mechanisms of lipofuscinoge-nesis. Res Commun Chem Pathol Pharmacol 47:415-426
59. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Mtflvig J, Pociot F, Johannesen J, Nerup J 1990 Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 164:169-193
60. Blough NV, Zafiriou OC 1985 Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg Chem 24:3502-3504
61. Moncada S, Palmer RMJ, Higgs EA 1991 Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142
62. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA 1990 Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624